Department of Chemistry and Biochemistry, Jackson State University, Jackson, MS 39217, USA.
Pharm Biol. 2011 May;49(5):464-70. doi: 10.3109/13880209.2010.523429. Epub 2011 Feb 1.
Vernonia amygdalina Del. (VA; Asteraceae or Compositae) is a small tree growing throughout tropical Africa. It is widely used for food and medicinal purposes by local people. It was reported that it had several qualities, including anticancer activity.
A sesquiterpene lactone, vernodalinol, was isolated from VA leaves. The first reported source of vernodalinol was in 2009 from a different plant, only (1)H NMR spectrum and no detailed structural analysis were carried out. No whole spectroscopic data were provided.
VA dried leaves were extracted with 85% ethanol followed by further separation into four fractions by liquid-liquid extraction technique using various solvents: hexane, chloroform, and n-butanol. Vernodalinol was separated from the n-butanol fraction by column chromatography. The biological activity of vernodalinol was evaluated in estrogen receptor-positive (ER(+)) human breast carcinoma cells (MCF-7) in vitro.
Results indicated that vernodalinol (25 and 50 μg/mL) inhibited breast cancerous cell growth (DNA synthesis) by 34% (P < 0.025) and 40% (P < 0.025), respectively. It is reasonable to expect an LC(50) of 70-75 μg/mL for vernodalinol in MCF-7 cells.
Vernodalinol structure was confirmed using a battery of spectroscopic methods, 1D and 2D NMR, high-resolution mass spectrometry (HR-MS), UV, IR, and X-ray. These results suggest that vernodalinol, although it has some biological activity, is likely to work in concert with other ingredients responsible for the anticancer activity exhibited of VA.
Vernonia amygdalina Del.(VA;菊科或菊科)是一种在整个热带非洲生长的小乔木。它被当地人广泛用于食品和药用目的。据报道,它具有几种特性,包括抗癌活性。
从 VA 叶片中分离出一种倍半萜内酯,vernodalinol。vernodalinol 的第一个报道来源是在 2009 年,来自另一种植物,仅进行了(1)H NMR 光谱分析,没有进行详细的结构分析。没有提供完整的光谱数据。
VA 干叶用 85%乙醇提取,然后通过液液萃取技术进一步分离成四个部分,使用不同的溶剂:正己烷、氯仿和正丁醇。vernodalinol 从正丁醇部分通过柱色谱分离。vernodalinol 的生物活性在体外评估在雌激素受体阳性(ER(+))人乳腺癌细胞(MCF-7)中。
结果表明 vernodalinol(25 和 50 μg/mL)分别抑制乳腺癌细胞生长(DNA 合成)34%(P < 0.025)和 40%(P < 0.025)。vernodalinol 在 MCF-7 细胞中的 LC(50) 合理预期为 70-75 μg/mL。
vernodalinol 结构使用一系列光谱方法、1D 和 2D NMR、高分辨率质谱(HR-MS)、UV、IR 和 X 射线进行了确认。这些结果表明,vernodalinol 虽然具有一些生物活性,但可能与其他负责 VA 表现出的抗癌活性的成分协同作用。